BIOMAT Database Logo BIOMAT Database Logo

New broad-spectrum cephalosporins with anti-pseudomonal activity. II. Synthesis and antibacterial activity of 7 beta-[2-acylamino-2-(4-hydroxyphenyl)acetamido]-3-[ (1-methyl-1H-tetrazol-5-yl)thiomethyl]ceph-3-em-4-carboxylic acids. 1983

H Yamada, and H Tobiki, and K Jimpo, and K Gooda, and Y Takeuchi, and S Ueda, and T Komatsu, and T Okuda, and H Noguchi, and K Irie, and T Nakagome

The influence of the chirality of the 7-acyl side chain and of various N-acyl moieties (A-CO-) on the in vitro activity of 7 beta-[2-acylamino-2-(4-hydroxyphenyl)acetamido ]-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]ceph-3-em-4-carboxylic acids (6) was investigated. A cephalosporin having a 7-acyl side chain of S-configuration (6r) was only weakly active against Staphylococcus aureus and Klebsiella pneumoniae and was inactive against the other species tested. Among the various N-acyl moieties in the cephalosporins having a 7-acyl side chain of the R-configuration, the 4-hydroxypyridine-3-carbonyl moiety, unsubstituted or substituted with 5-bromo and/or 6-alkyl groups and the 4-hydroxy-1,5-naphthyridine-3-carbonyl moiety, unsubstituted or substituted with a 6-methyl and a 6-methoxy group gave the most active compounds. N-Ethylation of the 4-hydroxy-1,5-naphthyridine-3-carbonyl derivative and the 4-hydroxypyridine-3-carbonyl derivative (6p, 6q) resulted in a decrease of the in vitro activity.

UI MeSH Term Description Entries
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

H Yamada, and H Tobiki, and K Jimpo, and K Gooda, and Y Takeuchi, and S Ueda, and T Komatsu, and T Okuda, and H Noguchi, and K Irie, and T Nakagome
A new cephalosporin. SCE-963: 7-[2-(2-aminothiazol-4-yl)-acetamido]-3-[[[1-(2-dimethylaminoethyl)-1h-tetrazol-5-yl]-thio]methyl]ceph-3-em-4-carboxylic acid. Chemistry and structure-activity relationships.
December 1978, The Journal of antibiotics,
H Yamada, and H Tobiki, and K Jimpo, and K Gooda, and Y Takeuchi, and S Ueda, and T Komatsu, and T Okuda, and H Noguchi, and K Irie, and T Nakagome
Preparation of 1-acyloxyethyl esters of 7-[2-(2-aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoe thy l)-1H-tetrazol-5-yl]thio]-methyl]ceph-3-em-4-carboxylic acid (cefotiam) and their oral absorption in mice.
September 1986, The Journal of antibiotics,
H Yamada, and H Tobiki, and K Jimpo, and K Gooda, and Y Takeuchi, and S Ueda, and T Komatsu, and T Okuda, and H Noguchi, and K Irie, and T Nakagome
7 beta-[2-(2-Aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3-[(1,2,3- thiadiazol-5-yl)thiomethyl]-ceph-3-em-4-carboxylic acid. A new potent cephalosporin derivative.
February 1983, The Journal of antibiotics,
H Yamada, and H Tobiki, and K Jimpo, and K Gooda, and Y Takeuchi, and S Ueda, and T Komatsu, and T Okuda, and H Noguchi, and K Irie, and T Nakagome
Synthetic cephalosporins. VII. Synthesis and antibacterial activity of 7-[(Z)-2-(2-aminothiazol-4-yl)-2-(3-(3-hydroxy-4-pyridon-1-yl)-3- carboxypropoxyimino)acetamido]-3-(1,2,3-thiadiazol-5-yl)-thiomethyl-3- cephem-4-carboxylic acid and its related compounds.
December 1990, Chemical & pharmaceutical bulletin,
H Yamada, and H Tobiki, and K Jimpo, and K Gooda, and Y Takeuchi, and S Ueda, and T Komatsu, and T Okuda, and H Noguchi, and K Irie, and T Nakagome
Semisynthetic beta-lactam antibiotics. II. Synthesis and antibacterial activity of 7beta-[2-(acylamino)-2- (2-aminothiazol-4-yl)acetamido]cephalosporins.
September 1986, The Journal of antibiotics,
H Yamada, and H Tobiki, and K Jimpo, and K Gooda, and Y Takeuchi, and S Ueda, and T Komatsu, and T Okuda, and H Noguchi, and K Irie, and T Nakagome
[Synthetic cephalosporins. IV. Synthesis and antibacterial activity of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-(O-substituted oxyimino)acetamido]-3-(1,2,3-triazol-1-yl)methyl-3-cephem-4-carboxylic acid and related compounds].
December 1989, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
H Yamada, and H Tobiki, and K Jimpo, and K Gooda, and Y Takeuchi, and S Ueda, and T Komatsu, and T Okuda, and H Noguchi, and K Irie, and T Nakagome
Studies on monocyclic beta-lactam antibiotics. IV. Synthesis and antibacterial activity of (3S,4R)-3-[2-(2-aminothiazol-4-yl)-(Z)-2-(O-substituted oxyimino)acetamido]-4-methyl-1- (1H-tetrazol-5-yl)-2-azetidinones.
January 1986, The Journal of antibiotics,
H Yamada, and H Tobiki, and K Jimpo, and K Gooda, and Y Takeuchi, and S Ueda, and T Komatsu, and T Okuda, and H Noguchi, and K Irie, and T Nakagome
Synthesis and biological properties of some 3-[(N-substituted-amino)pyridinium-4-thiomethyl]-7-[2-(2-amino-thiazol- 4-yl)-2-(Z)-(methoxyimino)acetamido]ceph-3-em-4-carboxylates.
August 1993, The Journal of antibiotics,
H Yamada, and H Tobiki, and K Jimpo, and K Gooda, and Y Takeuchi, and S Ueda, and T Komatsu, and T Okuda, and H Noguchi, and K Irie, and T Nakagome
Structure--activity relationships in cephalosporins prepared from penicillins. 1. 7beta-Acylamino derivatives of 3-benzyl- and 3-(3-pyridylmethyl)ceph-3-em-4-carboxylic acids.
August 1977, Journal of medicinal chemistry,
H Yamada, and H Tobiki, and K Jimpo, and K Gooda, and Y Takeuchi, and S Ueda, and T Komatsu, and T Okuda, and H Noguchi, and K Irie, and T Nakagome
Synthesis and structure-activity relationships of 7 beta-[2-(2-aminothiazol-4-yl)acetamido]-cephalosporin derivatives. III. Synthesis and antibacterial activity of 7 beta-[2-amino-2-(2-aminothiazol-4-yl)acetamido]cephalosporins.
September 1980, The Journal of antibiotics,
Copied contents to your clipboard!